These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17530043)

  • 1. [New anti-pneumococcal vaccines. Beyond pneumococcus].
    Garcia-Sicilia Lopez J
    Rev Esp Quimioter; 2007 Mar; 20(1):119-21. PubMed ID: 17530043
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical and therapeutic changes in otitis with anti-pneumococcal vaccination].
    Baquero-Artigao F
    Rev Esp Quimioter; 2007 Mar; 20(1):122-4. PubMed ID: 17530044
    [No Abstract]   [Full Text] [Related]  

  • 3. Authors' reply to Prymula R. Re: "Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines" [Vaccine 27 (2009) 4739-4740].
    Rodgers GL; Arguedas A; Cohen R; Dagan R
    Vaccine; 2009 Sep; 27(40):5429-30. PubMed ID: 19643215
    [No Abstract]   [Full Text] [Related]  

  • 4. A pain in the ear: what has the 7-valent conjugated pneumococcal vaccine done to reduce the incidence of acute otitis media?
    Regelmann WE
    Clin Infect Dis; 2005 Jun; 40(12):1745-7. PubMed ID: 15909261
    [No Abstract]   [Full Text] [Related]  

  • 5. Complicated otitis media and its implications.
    Leibovitz E
    Vaccine; 2008 Dec; 26 Suppl 7():G16-9. PubMed ID: 19094932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Does vaccination affect the prescription of antibiotics?].
    Campos J
    Rev Esp Quimioter; 2007 Mar; 20(1):115-8. PubMed ID: 17530042
    [No Abstract]   [Full Text] [Related]  

  • 7. The impact of pneumococcal conjugate vaccines on otitis media-can we extrapolate to pneumonia?
    Dagan R
    Vaccine; 2008 Jun; 26 Suppl 2():B16-8. PubMed ID: 18793601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunization and antimicrobials. Is there an association between the effects against Streptococcus pneumoniae?].
    Aguilar L; Giménez MJ
    Rev Esp Quimioter; 2007 Mar; 20(1):125-7. PubMed ID: 17530045
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomized, controlled trial efficacy of pneumococcal conjugate vaccine against otitis media among Navajo and White Mountain Apache infants.
    O'Brien KL; David AB; Chandran A; Moulton LH; Reid R; Weatherholtz R; Santosham M
    Pediatr Infect Dis J; 2008 Jan; 27(1):71-3. PubMed ID: 18162944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving microbiology and molecular epidemiology of acute otitis media in the pneumococcal conjugate vaccine era.
    Pichichero ME; Casey JR
    Pediatr Infect Dis J; 2007 Oct; 26(10 Suppl):S12-6. PubMed ID: 18049375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Conclusions].
    Picazo JJ
    Rev Esp Quimioter; 2007 Mar; 20(1):150-1. PubMed ID: 17530049
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis.
    Pavia M; Bianco A; Nobile CG; Marinelli P; Angelillo IF
    Pediatrics; 2009 Jun; 123(6):e1103-10. PubMed ID: 19482744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumococcal vaccine concerns: shape-shifters and beyond.
    Singh NK
    Vaccine; 2007 Jul; 25(29):5244-5. PubMed ID: 17566614
    [No Abstract]   [Full Text] [Related]  

  • 14. Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines.
    Rodgers GL; Arguedas A; Cohen R; Dagan R
    Vaccine; 2009 Jun; 27(29):3802-10. PubMed ID: 19446378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of pneumococcal conjugate vaccine against PCR-positive acute otitis media.
    Palmu AA; Saukkoriipi A; Jokinen J; Leinonen M; Kilpi TM
    Vaccine; 2009 Mar; 27(10):1490-1. PubMed ID: 19168111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumococcal vaccination of adults: polysaccharide or conjugate.
    Med Lett Drugs Ther; 2009 Jun; 51(1314):47-8. PubMed ID: 19528887
    [No Abstract]   [Full Text] [Related]  

  • 17. Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species.
    Pletz MW; Maus U; Krug N; Welte T; Lode H
    Int J Antimicrob Agents; 2008 Sep; 32(3):199-206. PubMed ID: 18378430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into pneumococcal disease.
    Feldman C; Anderson R
    Respirology; 2009 Mar; 14(2):167-79. PubMed ID: 19272081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial-resistant Streptococcus pneumoniae: trends and management.
    Jacobs MR
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):619-35. PubMed ID: 18847402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Considerations on pediatric pneumococcal infection in Navarra].
    Bernaola E; Herranz M; Clerigué N; Torroba L; Gil F; Gil-Setas A
    Rev Esp Quimioter; 2007 Mar; 20(1):143-9. PubMed ID: 17530048
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.